Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Goethe University Frankfurt
Headquarters: Frankfurt, Germany
Website: http://www.goethe-universit...
Year Founded: 1914
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Nov 11, 2022
Discovery & Translation
S&K’s small molecule TNF inhibitor; plus Actym’s engineered bacteria platform and more
BioCentury’s roundup of translational news
BioCentury | Apr 17, 2021
Deals
As German translational science begins to bloom, Evotec, BMS launch incubator in Rhine-Main-Neckar region
Evotec’s latest ‘BRIDGE’ incubator comes with $20M to accelerate academic research
BioCentury | Jun 23, 2020
Distillery Therapeutics
Overexpressing OXCT1-AS1, a long non-coding RNA, for heart attacks
BioCentury | Apr 9, 2020
Product Development
April 8 COVID-19 roundup: National Academy of Sciences says COVID-19 could continue through summer; plus HHS, SAb-CSL, Vanda-UIC, Avacta-Cytiva and more
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
BioCentury | Sep 17, 2015
Distillery Therapeutics
Therapeutics: CREB binding protein (CREBBP; CBP); E1A binding protein p300 (EP300; p300); interleukin-17A (IL-17A)
Items per page:
1 - 10 of 27